AmerisourceBergen changes operating model, leadership team
VALLEY FORGE, Pa. — AmerisourceBergen on Monday shared its new organizational structure, which it said was aimed at aligning the company with its customers’ needs while accelerating growth and supporting its corporate strategy. As a result, its customer-facing offerings will be divided into two divisions — pharmaceutical distribution and strategic global sourcing and global commercialization services and animal health.
Group president Bob Mauch will lead the pharmaceutical distribution and strategic global sourcing group, which will include the company’s services to retail chain and independent pharmacies, health systems, physician practices and alternate care sites, as well as its sourcing, repackaging and specialty pharmacy capabilities. Within this group, Peyton Howell will assume a new role as president of health systems, physician practices and strategic health solutions.
Group president James Cleary, Jr., will head the company’s global commercialization services and pet health division, which will include AmerisourceBergen’s solutions for product commercialization and patient access, as well as international development and animal health.
“AmerisourceBergen has assembled and built best-in-class capabilities to support every stage of pharmaceutical care, with the goal of ensuring access to medicines that create healthier futures for patients,” AmerisourceBergen president, chairman and CEO Steve Collis said. “This strategy has served as the engine of AmerisourceBergen’s success and we are now evolving our organization to capitalize on our unique portfolio of services. Our vision is to accelerate AmerisourceBergen’s corporate growth by further aligning our operating model to the dynamic customer needs in the health and pharmaceutical industry.”
The company also has named a new management committee to facilitate faster decision-making. The group comprises:
- Chief legal and business officer John Chou, who will now oversee legal and regulatory affairs alongside strategy, innovation and business development and information technology;
- Chief communications and administration officer Gina Clark, who will now oversee marketing, communication, corporate citizenship and sustainability alongside human resources and government affairs
- CFO Tim Guttman; and
Additionally, AmerisourceBergen EVP and president of AmerisourceBergen Specialty Group will be departing the company for new opportunities, the company said, noting that he would stay on board for the next few months as he transitions from his role.
“We are better positioned to meet the needs of the marketplace because of James’ leadership and I’m truly grateful for his guidance and partnership over the past decade,” Collis said. “We will carry that industry leadership into our new management committee structure. This group will be singularly focused on aligning every aspect of AmerisourceBergen to our purpose, corporate strategy and continued growth. We believe this next evolution of AmerisourceBergen will enable the Company to be more nimble and effective, actively supporting our customers as they grow and unlock the full value of their businesses.”
For financial reporting purposes, AmerisourceBergen operations will continue to be divided into the Pharmaceutical Distribution Services reportable segment and other, the company said.
FDA approves Aurobindo’s Renvela generic
EAST WINDSOR, N.J. — Aurobindo Pharma USA on Monday announced that its had received Food and Drug Administration approval for its generic of Genzyme’s Renvela (sevelamer carbonate for oral suspension).
The drug is indicated for the control of serum phosphorus in patients with chronic kidney disease.
Aurobindo’s generic will be available in 08.- and 2.4-g pouches. The drug had a market size of $139.9 million for the 12 months ended April 2017, according to QuintilesIMS data.
Walgreens and Greater Than AIDS teams on free testing for 7th straight year
DEERFIELD, Ill. — Walgreens and Greater Than AIDS, a leading national public information response to the domestic HIV/AIDS epidemic, are teaming up for the seventh straight year with health departments and local AIDS service organizations to offer free HIV testing and counseling about prevention strategies, including Pre-Exposure Prophylaxis, as part of a National HIV Testing Day effort.
“We know more about preventing and treating HIV than ever before,” stated Tina Hoff, SVP and director, health communication and media partnerships, Kaiser Family Foundation, which directs Greater Than AIDS. “The first step is knowing your status. This collaboration normalizes HIV testing as part of everyday life, while educating communities about the latest advances.”
Testing will be available at more than 220 participating Walgreens stores in 130 cities, including Atlanta, Chicago, Houston, New Orleans and Memphis, among other cities, on June 27 and 28 from 3 p.m. to 7 p.m. (local time) both days. Results are provided on site by trained counselors. Alere North America, bioLytical Laboratories and OraSure have donated test kits for the activation.
PrEP, a medication available by prescription, offers another effective means of protection for those without HIV. In addition, antiretrovirals, the medications used to treat HIV in addition to improving health, are now known to help stop the spread of the virus. The Centers for Disease Control and Prevention recommends HIV testing as part of routine health care.
“With early diagnosis and treatment, someone with HIV can live a healthy normal lifespan,” said Glen Pietrandoni, senior director of virology at Walgreens. “It’s very important to take control of your health by getting a test and learning your status. Results are provided within minutes, on-site by trained counselors.”